CVI was way over sold.On the close 1 buyer came in for 1,000,000 shares, so that shows buyer confidence.CVI will be back to 6 cents
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%